Bone Biologics Corp (BBLG)
1.19
-0.10
(-7.75%)
USD |
NASDAQ |
Nov 15, 16:00
1.24
+0.05
(+4.20%)
After-Hours: 20:00
Bone Biologics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Johnson & Johnson | 0.5096 |
| Dermata Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.194M |
| Total Liabilities (Quarterly) | 0.2845M |
| Shareholders Equity (Quarterly) | 2.909M |